Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants

Completed · Phase 1

Conditions studied: Healthy

In brief

This is a 2-part, open label, fixed-sequence study to evaluate the potential drug interaction between ALXN2050 and fluconazole (Part 1), and between ALXN2050 and rifampin (Part 2) in healthy adult participants. Part 1 will be a 2-period, fixed-sequence study. Part 2 will be a single-period, fixed-sequence study.

Key facts

Study ID
NCT04933682
Run by
Alexion Pharmaceuticals, Inc.
People needed
16
Starts
2021-06-07
Expected to finish
2021-08-23
Last updated by the study team
2026-07-16

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.